| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-207 |
Sentence |
denotes |
Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. |
| T1 |
0-207 |
Sentence |
denotes |
Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. |
| T1 |
0-207 |
Sentence |
denotes |
Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. |
| TextSentencer_T2 |
208-408 |
Sentence |
denotes |
Many nuclear and cytoplasmic proteins are O-glycosylated on serine or threonine residues with the monosaccharide beta-N-acetylglucosamine, which is then termed O-linked N-acetylglucosamine (O-GlcNAc). |
| T2 |
208-408 |
Sentence |
denotes |
Many nuclear and cytoplasmic proteins are O-glycosylated on serine or threonine residues with the monosaccharide beta-N-acetylglucosamine, which is then termed O-linked N-acetylglucosamine (O-GlcNAc). |
| T2 |
208-408 |
Sentence |
denotes |
Many nuclear and cytoplasmic proteins are O-glycosylated on serine or threonine residues with the monosaccharide beta-N-acetylglucosamine, which is then termed O-linked N-acetylglucosamine (O-GlcNAc). |
| TextSentencer_T3 |
409-563 |
Sentence |
denotes |
It has been shown that abnormal O-GlcNAc modification (O-GlcNAcylation) of proteins is one of the causes of insulin resistance and diabetic complications. |
| T3 |
409-563 |
Sentence |
denotes |
It has been shown that abnormal O-GlcNAc modification (O-GlcNAcylation) of proteins is one of the causes of insulin resistance and diabetic complications. |
| T3 |
409-563 |
Sentence |
denotes |
It has been shown that abnormal O-GlcNAc modification (O-GlcNAcylation) of proteins is one of the causes of insulin resistance and diabetic complications. |
| TextSentencer_T4 |
564-941 |
Sentence |
denotes |
In this study, in order to examine the relationship between O-GlcNAcylation of proteins and glucose-stimulated insulin secretion in noninsulin-dependent type (type 2) diabetes, we investigated the level of O-GlcNAcylation of proteins, especially that of PDX-1, and the expression of O-GlcNAc transferase in Goto-Kakizaki (GK) rats, which are an animal model of type-2 diabetes. |
| T4 |
564-941 |
Sentence |
denotes |
In this study, in order to examine the relationship between O-GlcNAcylation of proteins and glucose-stimulated insulin secretion in noninsulin-dependent type (type 2) diabetes, we investigated the level of O-GlcNAcylation of proteins, especially that of PDX-1, and the expression of O-GlcNAc transferase in Goto-Kakizaki (GK) rats, which are an animal model of type-2 diabetes. |
| T4 |
564-941 |
Sentence |
denotes |
In this study, in order to examine the relationship between O-GlcNAcylation of proteins and glucose-stimulated insulin secretion in noninsulin-dependent type (type 2) diabetes, we investigated the level of O-GlcNAcylation of proteins, especially that of PDX-1, and the expression of O-GlcNAc transferase in Goto-Kakizaki (GK) rats, which are an animal model of type-2 diabetes. |
| TextSentencer_T5 |
942-1184 |
Sentence |
denotes |
By immunoblot and immunohistochemical analyses, the expression of O-GlcNAc transferase protein and O-GlcNAc-modified proteins in whole pancreas and islets of Langerhans of 15-week-old diabetic GK rats and nondiabetic Wistar rats was examined. |
| T5 |
942-1184 |
Sentence |
denotes |
By immunoblot and immunohistochemical analyses, the expression of O-GlcNAc transferase protein and O-GlcNAc-modified proteins in whole pancreas and islets of Langerhans of 15-week-old diabetic GK rats and nondiabetic Wistar rats was examined. |
| T5 |
942-1184 |
Sentence |
denotes |
By immunoblot and immunohistochemical analyses, the expression of O-GlcNAc transferase protein and O-GlcNAc-modified proteins in whole pancreas and islets of Langerhans of 15-week-old diabetic GK rats and nondiabetic Wistar rats was examined. |
| TextSentencer_T6 |
1185-1344 |
Sentence |
denotes |
The expression of O-GlcNAc transferase at the protein level and O-GlcNAc transferase activity were increased significantly in the diabetic pancreas and islets. |
| T6 |
1185-1344 |
Sentence |
denotes |
The expression of O-GlcNAc transferase at the protein level and O-GlcNAc transferase activity were increased significantly in the diabetic pancreas and islets. |
| T6 |
1185-1344 |
Sentence |
denotes |
The expression of O-GlcNAc transferase at the protein level and O-GlcNAc transferase activity were increased significantly in the diabetic pancreas and islets. |
| TextSentencer_T7 |
1345-1447 |
Sentence |
denotes |
The diabetic pancreas and islets also showed an increase in total cellular O-GlcNAc-modified proteins. |
| T7 |
1345-1447 |
Sentence |
denotes |
The diabetic pancreas and islets also showed an increase in total cellular O-GlcNAc-modified proteins. |
| T7 |
1345-1447 |
Sentence |
denotes |
The diabetic pancreas and islets also showed an increase in total cellular O-GlcNAc-modified proteins. |
| TextSentencer_T8 |
1448-1492 |
Sentence |
denotes |
O-GlcNAcylation of PDX-1 was also increased. |
| T8 |
1448-1492 |
Sentence |
denotes |
O-GlcNAcylation of PDX-1 was also increased. |
| T8 |
1448-1492 |
Sentence |
denotes |
O-GlcNAcylation of PDX-1 was also increased. |
| TextSentencer_T9 |
1493-1622 |
Sentence |
denotes |
In the diabetic GK rats, significant increases in the immunoreactivities of both O-GlcNAc and O-GlcNAc transferase were observed. |
| T9 |
1493-1622 |
Sentence |
denotes |
In the diabetic GK rats, significant increases in the immunoreactivities of both O-GlcNAc and O-GlcNAc transferase were observed. |
| T9 |
1493-1622 |
Sentence |
denotes |
In the diabetic GK rats, significant increases in the immunoreactivities of both O-GlcNAc and O-GlcNAc transferase were observed. |
| TextSentencer_T10 |
1623-1773 |
Sentence |
denotes |
PUGNAc, an inhibitor of O-GlcNAcase, induced an elevation of O-GlcNAc level and a decrease of glucose-stimulated insulin secretion in isolated islets. |
| T10 |
1623-1773 |
Sentence |
denotes |
PUGNAc, an inhibitor of O-GlcNAcase, induced an elevation of O-GlcNAc level and a decrease of glucose-stimulated insulin secretion in isolated islets. |
| T10 |
1623-1773 |
Sentence |
denotes |
PUGNAc, an inhibitor of O-GlcNAcase, induced an elevation of O-GlcNAc level and a decrease of glucose-stimulated insulin secretion in isolated islets. |
| TextSentencer_T11 |
1774-2005 |
Sentence |
denotes |
These results indicate that elevation of the O-GlcNAcylation of proteins leads to deterioration of insulin secretion in the pancreas of diabetic GK rats, further providing evidence for the role of O-GlcNAc in the insulin secretion. |
| T11 |
1774-2005 |
Sentence |
denotes |
These results indicate that elevation of the O-GlcNAcylation of proteins leads to deterioration of insulin secretion in the pancreas of diabetic GK rats, further providing evidence for the role of O-GlcNAc in the insulin secretion. |
| T11 |
1774-2005 |
Sentence |
denotes |
These results indicate that elevation of the O-GlcNAcylation of proteins leads to deterioration of insulin secretion in the pancreas of diabetic GK rats, further providing evidence for the role of O-GlcNAc in the insulin secretion. |